Primary Job Title Founder & Chief Scientific Officer Primary Organization 
Naurex
Location Evanston, Illinois, United States Regions Greater Chicago Area, Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Joseph Moskal is chief scientific officer of Aptinyx. He founded Naurex and served as its chief scientific officer until the company was acquired by Allergan. He is also distinguished professor of biomedical engineering at Northwestern University and director of the university’s Falk Center for Molecular Therapeutics. Joseph Moskal previously
served as assistant professor and director of the neurosurgery laboratories at the Albert Einstein College of Medicine. Earlier, he was a staff fellow at the National Institutes of Health. Joseph Moskal is well known for his research on the NMDA receptor. He received a B.S. and a Ph.D. from the University of Notre Dame.
